Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: A prospective cohort study

Ron C. Li; Brian S. Finkelman; Jinbo Chen; Sarah L. Booth; Luanne Bershaw; Colleen Brensinger; Stephen E. Kimmel

doi:10.1160/TH13-02-0111

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2013; 109(01): 195-196
DOI: 10.1160/TH13-02-0111

Letters to the Editor

Schattauer GmbH

Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: A prospective cohort study

Authors

Ron C. Li

¹Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

⁵Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
Brian S. Finkelman

¹Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

²Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Jinbo Chen

¹Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Sarah L. Booth

³Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Philadelphia, Pennsylvania, USA
Luanne Bershaw

¹Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

²Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Colleen Brensinger

¹Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Stephen E. Kimmel

¹Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

²Center for Therapeutic Effectiveness Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

⁴Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

Abstract

Full Text

References

References
1 Rombouts EK, Rosendaal FR, Van der Meer FJM. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol 2010; 149: 598-605.
2 Sconce E, Khan T, Mason J. et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-875.
3 Pedersen F, Hamberg O, Hess K. et al. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 1991; 229: 517-520.
4 Ansell J, Hirsh J, Hylek E. et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (8th Edition). Chest 2008; 133 (06) Suppl: 160S-198S.
5 Platt AB, Localio AR, Brensinger CM. et al. Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest 2009; 137: 883-889.
6 Couris RR, Tataronis GR, Booth SL. et al. Development of a self-assessment instrument to determine daily intake and variability of dietary vitamin K. J Am Coll Nutr 2000; 19: 801-807.
7 Rosendaal F, Cannegieter S, Van der Meer F. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
8 Palareti G, Cosmi B. Bleeding with anticoagulation therapy who is at risk, and how best to identify such patients. Thromb Haemost 2009; 102: 268-278.
9 Booth SL, Centurelli M. Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutrition Rev 1999; 57: 288-296.
10 Johnson M. Influence of Vitamin K on Anticoagulant Therapy Depends on Vitamin K Status and the Source and Chemical Forms of Vitamin K. Nutrition Rev 2005; 63: 91-100.
11 Warren Grant Magnuson Clinical Center. National Institutes of Health Drug Interaction Task Force. Important information to know when you are taking: Coumadin® and vitamin K. 2003 Available at: http://ods.od.nih.gov/pubs/factsheets/coumad-in1.pdf
12 Thane CW, Paul aa, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ. Intake and sources of phylloquinone (vitamin K1): variation with sociodemographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 2007; 87: 605.
13 Sconce E, Avery P, Wynne H. et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-2423.

Supplementary Material

Online Supplementary Material (PDF) (PDF) (opens in new window)